Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Porteus

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Design and testing of zinc finger nucleases for use in mammalian cellsMatthew Porteus
Current Opinion in Pediatrics|October 18, 2012
Gene therapy for primary immunodeficienciesEric Kildebeck, Josh Checketts, Matthew Porteus
Circulation Research|March 4, 2017
Genome Editing in Cardiovascular BiologyTimon Seeger, Matthew Porteus, Joseph C Wu
Nature Methods|December 30, 2011
Gene editing: not just for translation anymoreMoira A McMahon, Meghdad Rahdar, Matthew Porteus
Nature Medicine|October 13, 2011
Zinc fingers hit off targetLinzhao Cheng, Bruce Blazar, Katherine High, et al.
JAMA|April 11, 2017
Toward Responsible Human Genome EditingRichard O Hynes, Barry S Coller, Matthew Porteus
Journal of the American Chemical Society|July 7, 2021
An Unusual "OR" Gate for Allosteric Regulation of Mammalian Transglutaminase 2 in the Extracellular MatrixArek V Melkonian, Elise Loppinet, Renata Martin, et al.
Cytotherapy|March 1, 2022
Design of experiments as a decision tool for cell therapy manufacturingEsmond Lee, Devin Shah, Matthew Porteus, et al.
Experimental Hematology|January 1, 2022
Hematopoietic stem cell gene editing and expansion: State-of-the-art technologies and recent applicationsMyriam L R Haltalli, Adam C Wilkinson, Alejo Rodriguez-Fraticelli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2025
Overcoming barriers to commercially pre-viable gene and cell therapies for rare and ultra-rare diseasesDavid Barrett, Paula M Cannon, Federico Mingozzi, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Design and testing of zinc finger nucleases for use in mammalian cellsMatthew Porteus
Current Opinion in Pediatrics|October 18, 2012
Gene therapy for primary immunodeficienciesEric Kildebeck, Josh Checketts, Matthew Porteus
Circulation Research|March 4, 2017
Genome Editing in Cardiovascular BiologyTimon Seeger, Matthew Porteus, Joseph C Wu
Nature Methods|December 30, 2011
Gene editing: not just for translation anymoreMoira A McMahon, Meghdad Rahdar, Matthew Porteus
Nature Medicine|October 13, 2011
Zinc fingers hit off targetLinzhao Cheng, Bruce Blazar, Katherine High, et al.
JAMA|April 11, 2017
Toward Responsible Human Genome EditingRichard O Hynes, Barry S Coller, Matthew Porteus
Journal of the American Chemical Society|July 7, 2021
An Unusual "OR" Gate for Allosteric Regulation of Mammalian Transglutaminase 2 in the Extracellular MatrixArek V Melkonian, Elise Loppinet, Renata Martin, et al.
Cytotherapy|March 1, 2022
Design of experiments as a decision tool for cell therapy manufacturingEsmond Lee, Devin Shah, Matthew Porteus, et al.
Experimental Hematology|January 1, 2022
Hematopoietic stem cell gene editing and expansion: State-of-the-art technologies and recent applicationsMyriam L R Haltalli, Adam C Wilkinson, Alejo Rodriguez-Fraticelli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2025
Overcoming barriers to commercially pre-viable gene and cell therapies for rare and ultra-rare diseasesDavid Barrett, Paula M Cannon, Federico Mingozzi, et al.
Pageof 5